Trolox (GMP) is Trolox (HY-101445) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Trolox is an analogue of vitamin E with a powerful antioxidant effect. Trolox is also a powerful inhibitor of membrane damage.
For research use only. We do not sell to patients.
- CAS No.: 53188-07-1
- Formula: C14H18O4
- Molecular Weight:250.29
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
Antiproliferative activity against human A549 cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| Erythrocyte | IC50 |
101 μM
Compound: trolox
|
Antioxidant activity assessed as inhibition of AAPH-induced hemolysis in rat RBC after 3 hrs
Antioxidant activity assessed as inhibition of AAPH-induced hemolysis in rat RBC after 3 hrs
|
[PMID: 12828473] |
| HBL-100 | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
Antiproliferative activity against human HBL100 cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| HeLa | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
Antiproliferative activity against human HeLa cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| HepG2 | IC50 |
>300 μM
Compound: TroH
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| HL-60 | IC50 |
0.3 μg/mL
Compound: Trolox
|
Antioxidant activity in PMA-stimulated Homo sapiens (human) HL60 cells assessed as inhibition of intracellular ROS generation incubated for 30 min prior to PMA stimulation measured after 30 min by DCFH-DA assay
Antioxidant activity in PMA-stimulated Homo sapiens (human) HL60 cells assessed as inhibition of intracellular ROS generation incubated for 30 min prior to PMA stimulation measured after 30 min by DCFH-DA assay
|
10.1007/s00044-011-9882-z |
| HL-60 | IC50 |
1.4 μM
Compound: Trolox
|
Inhibition of PMA induced ROS generation in human HL60 cells assessed as inhibition of ROA mediated oxidation of DCFH
Inhibition of PMA induced ROS generation in human HL60 cells assessed as inhibition of ROA mediated oxidation of DCFH
|
[PMID: 23547843] |
| HL-60 | IC50 |
3.6 μM
Compound: trolox
|
Antioxidant activity in human HL60 cells assessed as inhibition of TPA-stimulated hydrogen peroxide induced DCFH-DA oxidation by fluorometric microplate assay
Antioxidant activity in human HL60 cells assessed as inhibition of TPA-stimulated hydrogen peroxide induced DCFH-DA oxidation by fluorometric microplate assay
|
[PMID: 16562834] |
| MCF7 | IC50 |
>300 μM
Compound: TroH
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| MCF7 | IC50 |
1461 μM
Compound: 14
|
Compound was tested for antiproliferative activity against human breast cancer cell line MCF-7 in MTT assay
Compound was tested for antiproliferative activity against human breast cancer cell line MCF-7 in MTT assay
|
[PMID: 9873556] |
| Melan-a | IC50 |
>300 μM
Compound: 2
|
Depigmentation activity in mouse Melan-a cells assessed as inhibition of melanin formation after 4 days
Depigmentation activity in mouse Melan-a cells assessed as inhibition of melanin formation after 4 days
|
[PMID: 22071299] |
| Melan-a | IC50 |
300 μM
Compound: 2
|
Cytotoxicity against mouse Melan-a cells by modified crystal voilet assay
Cytotoxicity against mouse Melan-a cells by modified crystal voilet assay
|
[PMID: 22071299] |
| MT4 | IC50 |
200 μM
Compound: TroH
|
Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| NRK-52E | EC50 |
1.9 μM
Compound: Trolox
|
Cytoprotective activity against LPS-induced NRK-52E cells assessed as reduction in cell death measured every 5 min for 72 hrs by xCELLigence based RTCA analysis
Cytoprotective activity against LPS-induced NRK-52E cells assessed as reduction in cell death measured every 5 min for 72 hrs by xCELLigence based RTCA analysis
|
[PMID: 32141747] |
| PC-12 | IC50 |
20 μM
Compound: Trolox
|
Antioxidant activity in rat PC12 cells assessed as inhibition of Fe2+-induced ROS production after 1 hr by DCFH-DA staining-based fluorometric analysis
Antioxidant activity in rat PC12 cells assessed as inhibition of Fe2+-induced ROS production after 1 hr by DCFH-DA staining-based fluorometric analysis
|
[PMID: 23751098] |
| PC-12 | IC50 |
20 μM
Compound: Trolox
|
Antioxidant activity in rat PC12 cells assessed as inhibition of Fe2+-induced reactive oxygen species formation after 1 hr by DCFH-DA dye-based fluorometric analysis
Antioxidant activity in rat PC12 cells assessed as inhibition of Fe2+-induced reactive oxygen species formation after 1 hr by DCFH-DA dye-based fluorometric analysis
|
[PMID: 26447940] |
| RAW264.7 | IC50 |
30 μM
Compound: Trx
|
Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced ROS production measured after 4 hrs by H2DCFDA-AM probe based fluorescence assay
Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced ROS production measured after 4 hrs by H2DCFDA-AM probe based fluorescence assay
|
[PMID: 29275229] |
| RPMI-8226 | IC50 |
>300 μM
Compound: TroH
|
Cytotoxicity against human RPMI8226 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human RPMI8226 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| SH-SY5Y | IC50 |
49.55 μM
Compound: Trolox
|
Antioxidant activity against tert-butyl hydroperoxide-induced ROS evoked cell death in human SH-SY5Y cells
Antioxidant activity against tert-butyl hydroperoxide-induced ROS evoked cell death in human SH-SY5Y cells
|
[PMID: 18605718] |
| SH-SY5Y | IC50 |
82.3 μM
Compound: Trolox
|
Antioxidant activity in human SH-SY5Y cells assessed as inhibition of H2O2-induced DCFH oxidation measured after 1 hr by DCFH-DA dye based fluorescence assay
Antioxidant activity in human SH-SY5Y cells assessed as inhibition of H2O2-induced DCFH oxidation measured after 1 hr by DCFH-DA dye based fluorescence assay
|
[PMID: 27541262] |
| SW1573 | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
Antiproliferative activity against human SW1573 cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| T47D | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
Antiproliferative activity against human T47D cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
| U-937 | IC50 |
300 μM
Compound: TroH
|
Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT assay
Cytotoxicity against human U937 cells assessed as reduction in cell viability after 72 hrs by MTT assay
|
[PMID: 27344490] |
| WiDr | GI50 |
>100 μM
Compound: 2a
|
Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
Antiproliferative activity against human WiDr cells after 48 hrs by SRB assay
|
[PMID: 29129514] |
Trolox (GMP) has shown to protect mammalian cells from oxidative damage. Trolox (GMP) is effective in preventing myocyte necrosis in cell culture studies and in a canine model of two hours of left anterior descending coronary artery (LAD) occlusion followed by four hours of reperfusion[1].
Trolox (GMP) could prevent oxidative stress-induced apoptosis in thymocytes. Pre- or post-treatment of cells with Trolox (GMP) reduced H2O2-induced DNA fragmentation to control levels and below. [2].
Trolox (GMP) is a hydrophilic analog of alpha-tocopherol and reported to scavenge peroxyl radicals better than vitamin E in sodium dodecyl sulfate micelles and in liposomes. Trolox (GMP) prolongs substantially the survival of human ventricular myocytes and hepatocyte against oxyradicals generated with xanthine oxidase plus hypoxanthine, and prevented lysis of red cells exposed to an azo-initiator[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 53188-07-1
-
Molecular Weight 250.29
-
Formula C14H18O4
-
SMILES
O=C(C1(C)CCC2=C(C)C(O)=C(C)C(C)=C2O1)O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Mickle DA, et al. Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction. Ann Thorac Surg. 1989 Apr;47(4):553-7. [Content Brief]
[2]. Forrest VJ, et al. Oxidative stress-induced apoptosis prevented by Trolox. Free Radic Biol Med. 1994 Jun;16(6):675-84. [Content Brief]
[3]. Wu TW, et al. The cytoprotective effect of Trolox demonstrated with three types of human cells. Biochem Cell Biol. 1990 Oct;68(10):1189-94. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)